Annual Total Liabilities
$12.68 M
+$1.20 M+10.42%
December 31, 2023
Summary
- As of February 8, 2025, LPTX annual total liabilities is $12.68 million, with the most recent change of +$1.20 million (+10.42%) on December 31, 2023.
- During the last 3 years, LPTX annual total liabilities has risen by +$4.96 million (+64.30%).
- LPTX annual total liabilities is now -88.11% below its all-time high of $106.69 million, reached on December 31, 2016.
Performance
LPTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$16.09 M
+$455.00 K+2.91%
September 30, 2024
Summary
- As of February 8, 2025, LPTX quarterly total liabilities is $16.09 million, with the most recent change of +$455.00 thousand (+2.91%) on September 30, 2024.
- Over the past year, LPTX quarterly total liabilities has increased by +$3.41 million (+26.88%).
- LPTX quarterly total liabilities is now -84.92% below its all-time high of $106.69 million, reached on December 31, 2016.
Performance
LPTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LPTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.4% | +26.9% |
| 3 y3 years | +64.3% | -79.4% |
| 5 y5 years | +28.1% | -79.4% |
LPTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.5% | -79.4% | +119.1% |
| 5 y | 5-year | at high | +64.3% | -79.4% | +119.1% |
| alltime | all time | -88.1% | +543.5% | -84.9% | +2689.1% |
Leap Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.09 M(+2.9%) |
| Jun 2024 | - | $15.64 M(+47.7%) |
| Mar 2024 | - | $10.59 M(-16.5%) |
| Dec 2023 | $12.68 M(+10.4%) | $12.68 M(+14.9%) |
| Sep 2023 | - | $11.04 M(-6.5%) |
| Jun 2023 | - | $11.80 M(-84.9%) |
| Mar 2023 | - | $78.22 M(+580.9%) |
| Dec 2022 | $11.49 M(+14.6%) | $11.49 M(-5.0%) |
| Sep 2022 | - | $12.09 M(+11.1%) |
| Jun 2022 | - | $10.88 M(+48.2%) |
| Mar 2022 | - | $7.34 M(-26.7%) |
| Dec 2021 | $10.02 M(+29.8%) | $10.02 M(-11.0%) |
| Sep 2021 | - | $11.26 M(+39.8%) |
| Jun 2021 | - | $8.06 M(+8.5%) |
| Mar 2021 | - | $7.43 M(-3.8%) |
| Dec 2020 | $7.72 M(-16.1%) | $7.72 M(+4.2%) |
| Sep 2020 | - | $7.41 M(-6.7%) |
| Jun 2020 | - | $7.94 M(-26.3%) |
| Mar 2020 | - | $10.78 M(+17.2%) |
| Dec 2019 | $9.20 M | $9.20 M(+7.2%) |
| Sep 2019 | - | $8.58 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $9.20 M(+2.0%) |
| Mar 2019 | - | $9.02 M(-8.9%) |
| Dec 2018 | $9.90 M(-44.8%) | $9.90 M(-51.7%) |
| Sep 2018 | - | $20.50 M(-8.0%) |
| Jun 2018 | - | $22.27 M(-1.3%) |
| Mar 2018 | - | $22.56 M(+25.7%) |
| Dec 2017 | $17.95 M(-83.2%) | $17.95 M(+199.4%) |
| Sep 2017 | - | $5.99 M(+37.0%) |
| Jun 2017 | - | $4.38 M(-5.1%) |
| Mar 2017 | - | $4.61 M(-95.7%) |
| Dec 2016 | $106.69 M(+49.1%) | $106.69 M(>+9900.0%) |
| Jun 2016 | - | $577.00 K(-99.2%) |
| Dec 2015 | $71.55 M(+2775.8%) | $71.55 M(+2512.2%) |
| Sep 2015 | - | $2.74 M(-2.5%) |
| Jun 2015 | - | $2.81 M(-0.4%) |
| Mar 2015 | - | $2.82 M(+13.4%) |
| Dec 2014 | $2.49 M(+26.2%) | $2.49 M(+26.2%) |
| Sep 2014 | - | $1.97 M(-38.3%) |
| Jun 2014 | - | $3.19 M(+16.4%) |
| Mar 2014 | - | $2.75 M(+39.3%) |
| Dec 2013 | $1.97 M(-57.3%) | $1.97 M |
| Dec 2012 | $4.61 M | - |
FAQ
- What is Leap Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Leap Therapeutics?
- What is Leap Therapeutics annual total liabilities year-on-year change?
- What is Leap Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Leap Therapeutics?
- What is Leap Therapeutics quarterly total liabilities year-on-year change?
What is Leap Therapeutics annual total liabilities?
The current annual total liabilities of LPTX is $12.68 M
What is the all time high annual total liabilities for Leap Therapeutics?
Leap Therapeutics all-time high annual total liabilities is $106.69 M
What is Leap Therapeutics annual total liabilities year-on-year change?
Over the past year, LPTX annual total liabilities has changed by +$1.20 M (+10.42%)
What is Leap Therapeutics quarterly total liabilities?
The current quarterly total liabilities of LPTX is $16.09 M
What is the all time high quarterly total liabilities for Leap Therapeutics?
Leap Therapeutics all-time high quarterly total liabilities is $106.69 M
What is Leap Therapeutics quarterly total liabilities year-on-year change?
Over the past year, LPTX quarterly total liabilities has changed by +$3.41 M (+26.88%)